vTv Therapeutics Inc.
VTVT
$15.35
-$0.65-4.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.00K | 1.02M | 1.00M | 1.00M | 1.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.00K | 1.02M | 1.00M | 1.00M | 1.00M |
| Cost of Revenue | -3.41M | -3.57M | 5.65M | 5.25M | 5.13M |
| Gross Profit | 3.44M | 4.61M | -4.65M | -4.25M | -4.13M |
| SG&A Expenses | 13.35M | 13.65M | 13.55M | 12.81M | 12.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.07M | 25.20M | 25.00M | 23.86M | 24.70M |
| Operating Income | -25.06M | -24.18M | -24.00M | -22.86M | -23.70M |
| Income Before Tax | -22.90M | -22.61M | -22.61M | -25.31M | -26.11M |
| Income Tax Expenses | 0.00 | 100.00K | 100.00K | 100.00K | 100.00K |
| Earnings from Continuing Operations | -22.90 | -22.71 | -22.71 | -25.41 | -26.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.21M | 4.24M | 4.40M | 5.23M | 5.60M |
| Net Income | -18.69M | -18.46M | -18.31M | -20.18M | -20.62M |
| EBIT | -25.06M | -24.18M | -24.00M | -22.86M | -23.70M |
| EBITDA | -24.98M | -24.09M | -23.91M | -22.77M | -23.61M |
| EPS Basic | -3.01 | -3.00 | -4.11 | -6.43 | -8.31 |
| Normalized Basic EPS | -1.63 | -1.61 | -2.18 | -3.36 | -4.33 |
| EPS Diluted | -3.01 | -3.00 | -4.11 | -6.43 | -8.31 |
| Normalized Diluted EPS | -1.63 | -1.61 | -2.18 | -3.36 | -4.33 |
| Average Basic Shares Outstanding | 25.03M | 24.85M | 20.35M | 16.98M | 12.66M |
| Average Diluted Shares Outstanding | 25.03M | 24.85M | 20.35M | 16.98M | 12.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |